Due to the lack of complete human epidermal growth factor receptor 2 (HER2) status data, this study only analyzed the correlation between XRCC5/6 polymorphisms and the risk of breast cancer by different hormone receptor states, but not molecular subtypes. Here, ERBB2 is linked to breast cancer.